ArticleInternational journal of clinical oncology2023

Rubicon can predict prognosis in patients with pancreatic ductal adenocarcinoma after neoadjuvant chemoradiotherapy.

Daiki Marukawa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.